123 related articles for article (PubMed ID: 11534760)
21. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
22. In vitro anti-Helicobacter pylori activity of diallyl sulphides and protocatechuic acid.
Liu WH; Hsu CC; Yin MC
Phytother Res; 2008 Jan; 22(1):53-7. PubMed ID: 17705145
[TBL] [Abstract][Full Text] [Related]
23. In vitro inhibition of Helicobacter pylori by extracts of thyme.
Tabak M; Armon R; Potasman I; Neeman I
J Appl Bacteriol; 1996 Jun; 80(6):667-72. PubMed ID: 8698668
[TBL] [Abstract][Full Text] [Related]
24. Neutralizing antibodies for Helicobacter pylori urease inhibit bacterial colonization in the murine stomach in vivo.
Takeshita H; Watanabe E; Norose Y; Ito Y; Takahashi H
Biomed Res; 2019; 40(2):87-95. PubMed ID: 30982804
[TBL] [Abstract][Full Text] [Related]
25. In vitro anti-Helicobacter pylori activity of some flavonoids and their metabolites.
Bae EA; Han MJ; Kim DH
Planta Med; 1999 Jun; 65(5):442-3. PubMed ID: 10454900
[TBL] [Abstract][Full Text] [Related]
26. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
Dickey W; Kenny BD; McConnell JB
Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
[TBL] [Abstract][Full Text] [Related]
27. Preparation of specific anti-Helicobacter pylori yolk antibodies and their antibacterial effects.
Wang B; Yang J; Cao S; Wang H; Pan X; Zhu J; Zhou Y; Gao L; Li W; Li M
Int J Clin Exp Pathol; 2014; 7(10):6430-7. PubMed ID: 25400721
[TBL] [Abstract][Full Text] [Related]
28. Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study.
Saniee P; Shahreza S; Siavoshi F
Helicobacter; 2016 Apr; 21(2):143-52. PubMed ID: 26222264
[TBL] [Abstract][Full Text] [Related]
29. Gastro protective and H(+), K(+)-ATPase/H. pylori inhibitory properties of pectic polysaccharides from potato.
Badanavalu Chandrashekar K; Dharmesh SM
Int J Biol Macromol; 2016 Mar; 84():385-93. PubMed ID: 26704999
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo anti-Helicobacter pylori activity of Calophyllum brasiliense Camb.
Souza Mdo C; Beserra AM; Martins DC; Real VV; Santos RA; Rao VS; Silva RM; Martins DT
J Ethnopharmacol; 2009 Jun; 123(3):452-8. PubMed ID: 19501278
[TBL] [Abstract][Full Text] [Related]
31. Antifeedant and Antifungal Activities of Metabolites Isolated from the Coculture of Endophytic Fungus Aspergillus tubingensis S1120 with Red Ginseng.
Wu YM; Yang XQ; Zhao TD; Shi WZ; Sun LJ; Cen RH; Yang YB; Ding ZT
Chem Biodivers; 2022 Jan; 19(1):e202100608. PubMed ID: 34786852
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Helicobacter pylori and Its Associated Urease by Palmatine: Investigation on the Potential Mechanism.
Zhou JT; Li CL; Tan LH; Xu YF; Liu YH; Mo ZZ; Dou YX; Su R; Su ZR; Huang P; Xie JH
PLoS One; 2017; 12(1):e0168944. PubMed ID: 28045966
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
Sjöström JE; Larsson H
J Med Microbiol; 1996 Jun; 44(6):425-33. PubMed ID: 8636959
[TBL] [Abstract][Full Text] [Related]
34. Imaging induction of cytoprotective enzymes in intact human cells: coumberone, a metabolic reporter for human AKR1C enzymes reveals activation by panaxytriol, an active component of red ginseng.
Halim M; Yee DJ; Sames D
J Am Chem Soc; 2008 Oct; 130(43):14123-8. PubMed ID: 18826220
[TBL] [Abstract][Full Text] [Related]
35. Anti-secretory, anti-inflammatory and anti-Helicobacter pylori activities of several fractions isolated from Piper carpunya Ruiz & Pav.
Quílez A; Berenguer B; Gilardoni G; Souccar C; de Mendonça S; Oliveira LF; Martín-Calero MJ; Vidari G
J Ethnopharmacol; 2010 Apr; 128(3):583-9. PubMed ID: 20152892
[TBL] [Abstract][Full Text] [Related]
36. How Helicobacter pylori urease may affect external pH and influence growth and motility in the mucus environment: evidence from in-vitro studies.
Sidebotham RL; Worku ML; Karim QN; Dhir NK; Baron JH
Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):395-401. PubMed ID: 12655260
[TBL] [Abstract][Full Text] [Related]
37. In vitro inhibitory effect of flavonoids on growth, infection and vacuolation of Helicobacter pylori.
Shin JE; Kim JM; Bae EA; Hyun YJ; Kim DH
Planta Med; 2005 Mar; 71(3):197-201. PubMed ID: 15770537
[TBL] [Abstract][Full Text] [Related]
38. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX
Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962
[TBL] [Abstract][Full Text] [Related]
39. Multifaceted cytoprotection by synthetic polyacetylenes inspired by the ginseng-derived natural product, panaxytriol.
Chou TC; Dong H; Zhang X; Lei X; Hartung J; Zhang Y; Lee JH; Wilson RM; Danishefsky SJ
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14336-41. PubMed ID: 21844359
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial activity of Chamomilla recutita oil extract against Helicobacter pylori.
Shikov AN; Pozharitskaya ON; Makarov VG; Kvetnaya AS
Phytother Res; 2008 Feb; 22(2):252-3. PubMed ID: 17724768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
